Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 4/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 3/20 | 0.59 |
| ▸ | CASP6 | P55212 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | BRD4 | O60885 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.59 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.59 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.59 |
| ▸ | HTR2C | P28335 | 1/20 | 0.59 |
| ▸ | CTH | P32929 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methoxymethane SCHEMBL7777573 | 0.93 | CTSB (0.86) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| Benzoic Acid SCHEMBL20788024 | 0.88 | CTSB (0.77) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL2769398 | 0.88 | CTSB (0.78) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL7788656 | 0.87 | TDP1 (0.80) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL5528271 | 0.83 | CTSB (0.69) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL1774360 | 0.82 | CTSB (0.67) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL11058082 | 0.81 | CTSB (0.68) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL28978906 | 0.81 | CTSB (0.68) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL28307479 | 0.80 | CTSB (0.67) | CTSBTDP1ALDH1A1MAPTCASP6 | |
| SCHEMBL17058720 | 0.79 | CTSB (0.65) | CTSBTDP1ALDH1A1MAPTCASP6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 453 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114106341-B | Comb copolymer, preparation method and application thereof | 广州立邦涂料有限公司 | 2025-05-02 | — | — | CN | claimed |
| CN-116751162-B | Quinoline compound, preparation method thereof, pharmaceutical composition and medical application | 中国人民解放军军事科学院军事医学研究院 | 2025-02-28 | — | — | CN | claimed |
| CN-119297188-A | Preparation method of nanosheet-organic active molecule-catalyst hybrid material and application of nanosheet-organic active molecule-catalyst hybrid material in photoelectric storage integrated battery | 中国科学院大连化学物理研究所 | 2025-01-10 | — | — | CN | claimed |
| US-12163968-B2 | Preparation of nucleated RBC (NRBC) analogs for use as reference hematology controls in automated hematology analyzers | BIO-RAD LABORATORIES, INC. (US) | 2024-12-10 | — | — | US | claimed |
| CN-118479475-A | Preparation method of millimeter-sized spherical activated carbon with controllable specific surface area and porosity and millimeter-sized spherical activated carbon | 深圳大学 | 2024-08-13 | — | — | CN | claimed |
| CN-114369011-B | New green method for preparing 2-diaryl methyl substituted-1-naphthol compound | 湖南理工学院 | 2024-07-09 | — | — | CN | claimed |
| CN-117263826-A | Preparation method of MXene-organic molecule hybrid material and application of MXene-organic molecule hybrid material in photoelectric storage integrated battery | 中国科学院大连化学物理研究所 | 2023-12-22 | — | — | CN | claimed |
| CN-116751162-A | Quinoline compound, preparation method thereof, pharmaceutical composition and medical application | 中国人民解放军军事科学院军事医学研究院 | 2023-09-15 | — | — | CN | claimed |
| CN-116253644-A | Method for preparing 4-nitro-1-naphthol by dynamic tubular reactor | 山东兴文工业技术研究院有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-114563502-A | Method for synchronously and quantitatively determining concentrations of various aromatic compounds and metabolites in urine | 广东工业大学 | 2022-05-31 | — | — | CN | claimed |
| EP-1513828-A1 | NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS | Biovitrum AB (SE) | 2005-03-16 | — | — | EP | claimed |
| US-20040024210-A1 | New compounds | PROXIMAGEN NEUROSCIENCE PLC (GB) | 2004-02-05 | — | — | US | claimed |
| WO-2004000828-A1 | NEW COMPOUNDS USEFUL FOR THE TREATMENT OF OBESITY, TYPE II DIABETES AND CNS DISORDERS | BIOVITRUM AB (SE) | 2003-12-31 | — | — | WO | claimed |
| EP-0345551-B1 | EASILY FLOWABLE DELAYED CRYSTALLISING POLYARYLENE SULFIDE-MIXTURES | BAYER AG (DE) | 1993-09-08 | — | — | EP | claimed |
| EP-0252402-B1 | PROCESS FOR THE PREPARATION OF (2,2)-PARACYCLOPHANE AND DERIVATIVES THEREOF | Montedison S.p.A. (IT) | 1990-05-09 | — | — | EP | claimed |
| US-4816608-A | CATALYTIC HOFFMAN ELIMINATION OF P-METHYLBENZYLTRIMETHYL AMMONIUM HYDROXIDE | MONTEDISON S.P.A. (IT) | 1989-03-28 | — | — | US | claimed |
| EP-0252402-A1 | Process for the preparation of (2,2)-paracyclophane and derivatives thereof | Montedison S.p.A. (IT) | 1988-01-13 | — | — | EP | claimed |
| US-4196112-A | ADDUCT OF A BUTADIENE POLYMER AN A,B-ACID, A CARBOCYCLIC ALCOHOL GELATION INHIBITOR, A HYDROPHILIC SOLVENT, A NEUTRALIZER | NIPPON OIL CO., LTD. (JP) | 1980-04-01 | — | — | US | claimed |
| US-4175068-A | ADDUCT OF BUTADIENE AND UNSATURATED DICARBOXYLIC ACID, NEUTRALIZER | NIPPON OIL CO., LTD. (JP) | 1979-11-20 | — | — | US | claimed |
| US-3952023-A | Method for preparing adduct of butadiene polymer or copolymer and α, β-ethylenically unsaturated dicarboxylic acid compound | NIPPON OIL COMPANY LTD. (JA) | 1976-04-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040024210-A1 | New compounds | SULT1E1, SULT2A1, SULT1A1 | CTSB 1005/4885TDP1 3728/4885ALDH1A1 705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.